Karsten Boehnke

Molecular dissection of colorectal cancer in pre-clinical models identifies biomarkers predicting sensitivity to EGFR inhibitors

Moritz Schütte, Thomas S. Risch, Nilofar Abdavi-Azar et al. · Nature Communications · 2017 · 349 citations · Full text

Medicine, Molecular Medicine, Oncology +17

Genomic Aberrations that Activate D-type Cyclins Are Associated with Enhanced Sensitivity to the CDK4 and CDK6 Inhibitor Abemaciclib

Xueqian Gong, Lacey M. Litchfield, Yue Webster et al. · Cancer Cell · 2017 · 236 citations · Full text

Life Sciences, Genetics, Molecular Biology +14

Enhanced Efficacy of Simultaneous PD-1 and PD-L1 Immune Checkpoint Blockade in High-Grade Serous Ovarian Cancer

Changxin Wan, Matthew P. Keany, Han Dong et al. · Cancer Research · 2020 · 215 citations · Full text

Life Sciences, Immunology, Oncology +17

Preclinical characterization of abemaciclib in hormone receptor positive breast cancer

Raquel Torres-Guzmán, Bruna Calsina, Ana Hermoso et al. · Oncotarget · 2017 · 198 citations · Full text

Medicine, Oncology, Pharmacology +17

Assay Establishment and Validation of a High-Throughput Screening Platform for Three-Dimensional Patient-Derived Colon Cancer Organoid Cultures

Karsten Boehnke, Philip W. Iversen, Dirk Schumacher et al. · SLAS DISCOVERY · 2016 · 151 citations · Full text

Medicine, Cell Biology, Oncology +17